Complementary Therapy to Target LDL Cholesterol: The Role of the Ezetimibe/Simvastatin Combination

Cardiovascular (CV) disease remains the number 1 cause of death in the USA. Nonetheless, there has been a decline in the age-adjusted death rate for coronary heart disease (CHD) which may be due to more aggressive treatment guidelines for treating CV risk factors, such as hypertension, diabetes, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Ryan C, Jones, Peter H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993974/
https://www.ncbi.nlm.nih.gov/pubmed/17319467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993974/
https://www.ncbi.nlm.nih.gov/pubmed/17319467

Ejemplares similares